Palomar Holdings, Inc. (NASDAQ:PLMR) Given Average Recommendation of “Moderate Buy” by Brokerages

Palomar Holdings, Inc. (NASDAQ:PLMR) has earned an average recommendation of “Moderate Buy” from the eight ratings firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $158.1429.

Several equities analysts have issued reports on the company. Wall Street Zen lowered Palomar from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Keefe, Bruyette & Woods lifted their price objective on shares of Palomar from $170.00 to $171.00 and gave the company an “outperform” rating in a research note on Tuesday, January 6th. Weiss Ratings raised shares of Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, January 14th. JPMorgan Chase & Co. raised their price target on shares of Palomar from $145.00 to $155.00 and gave the stock an “overweight” rating in a report on Wednesday, January 7th. Finally, Evercore ISI began coverage on shares of Palomar in a report on Monday. They set an “outperform” rating and a $150.00 price objective on the stock.

Palomar Price Performance

Shares of PLMR opened at $127.01 on Friday. The business has a 50-day moving average of $128.42 and a 200-day moving average of $123.23. Palomar has a 1 year low of $107.75 and a 1 year high of $175.85. The company has a market capitalization of $3.37 billion, a price-to-earnings ratio of 17.69 and a beta of 0.44.

Palomar (NASDAQ:PLMR) last announced its earnings results on Wednesday, February 11th. The company reported $2.24 EPS for the quarter, beating the consensus estimate of $2.06 by $0.18. Palomar had a return on equity of 23.48% and a net margin of 22.50%.The company had revenue of $492.63 million for the quarter, compared to analyst estimates of $204.58 million. During the same quarter in the prior year, the company earned $1.52 EPS. The firm’s revenue for the quarter was up 62.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that Palomar will post 5.99 EPS for the current year.

Insiders Place Their Bets

In related news, insider Angela L. Grant sold 260 shares of the company’s stock in a transaction that occurred on Saturday, January 31st. The stock was sold at an average price of $121.75, for a total transaction of $31,655.00. Following the transaction, the insider directly owned 7,033 shares of the company’s stock, valued at approximately $856,267.75. This represents a 3.57% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO T Christopher Uchida sold 545 shares of the stock in a transaction that occurred on Saturday, January 31st. The stock was sold at an average price of $121.74, for a total value of $66,348.30. Following the completion of the transaction, the chief financial officer owned 14,005 shares in the company, valued at approximately $1,704,968.70. The trade was a 3.75% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 58,998 shares of company stock worth $7,255,669 over the last three months. Insiders own 3.70% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Allworth Financial LP raised its position in Palomar by 1,970.0% in the 2nd quarter. Allworth Financial LP now owns 207 shares of the company’s stock valued at $32,000 after buying an additional 197 shares during the last quarter. Salomon & Ludwin LLC bought a new position in shares of Palomar in the third quarter valued at approximately $25,000. Richardson Financial Services Inc. grew its holdings in shares of Palomar by 210.0% in the third quarter. Richardson Financial Services Inc. now owns 217 shares of the company’s stock valued at $25,000 after acquiring an additional 147 shares in the last quarter. Geneos Wealth Management Inc. bought a new stake in Palomar during the fourth quarter worth $32,000. Finally, Hollencrest Capital Management lifted its holdings in Palomar by 56.5% during the second quarter. Hollencrest Capital Management now owns 313 shares of the company’s stock worth $48,000 after acquiring an additional 113 shares during the period. Hedge funds and other institutional investors own 90.25% of the company’s stock.

Palomar News Summary

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Q4 beats and raised 2026 guidance — Palomar reported adjusted EPS of $2.24 (beat) and strong revenue/premium growth; management gave a full‑year 2026 adjusted net income outlook of $260M–$275M, signaling confidence in continued growth. Palomar Q4 Earnings & Revenues Beat Estimates, Premiums Rise Y/Y
• Positive Sentiment: Strong underlying growth — Gross written premiums rose ~31–32% in Q4 and FY2025; full‑year adjusted net income jumped ~62% year‑over‑year, showing scale from acquisitions and product expansion. Palomar Holdings, Inc. Reports Strong Fourth Quarter and Full Year 2025 Results
• Neutral Sentiment: New analyst/institutional attention — Evercore ISI initiated coverage and industry write‑ups compare Palomar to peers (e.g., Root), which may increase trading interest but not directly change fundamentals. Evercore ISI Initiates Coverage on Palomar (NASDAQ:PLMR)
• Neutral Sentiment: Earnings writeups and call availability — Multiple outlets summarized the results and the company hosted a conference call; listen for management commentary on loss trends and M&A execution. MarketBeat Q4 Summary & Conference Call
• Negative Sentiment: Underwriting metrics deteriorated — Q4 total loss ratio rose to 30.4% (from 25.7% a year ago) and the adjusted combined ratio widened to ~73–74% (vs. ~71–72% prior). Rising non‑catastrophe losses and a higher combined ratio create concern that margin expansion may be harder to sustain. Compared to Estimates, Palomar (PLMR) Q4 Earnings: A Look at Key Metrics
• Negative Sentiment: Spike in non‑cat losses and notable insider/institutional selling — Reports flag a large increase in non‑catastrophe losses and heavy insider sales activity (many insider sales vs. few purchases), plus several large funds trimmed positions — a catalyst for profit‑taking. Quiver Quant: Q4 Results, Loss Trends, Insider/Institutional Activity

About Palomar

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.